Clinical Trial Update: Efficacy and Safety of Ustekinumab in Patients With Moderate to Severe Palmar Plantar Psoriasis [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy and safety of ustekinumab in patients with moderate to severe palmoplantar psoriasis; results were posted in M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmoplantar Psoriasis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Tufts Medical Center | Conditions: Moderate to Severe Palmar Plantar Psoriasis | NA | Status: COMPLETED | Results posted: 2013-03-11